Filana Therapeutics, Inc.
MX ˙ BMV ˙ US14817C1071
SecurityMX:FLNA / Filana Therapeutics, Inc.
InstitutionGallacher Capital Management LLC
Latest Disclosed Ownership64,972 shares
Latest Disclosed Value $ 109,803
Gallacher Capital Management LLC ownership in FLNA / Filana Therapeutics, Inc.

On May 5, 2026 - Gallacher Capital Management LLC filed a 13F-HR form disclosing ownership of 64,972 shares of Filana Therapeutics, Inc. (MX:FLNA) valued at $109,803 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 3, 2026 disclosing 64,975 shares of Filana Therapeutics, Inc.. This represents a change in shares of -0.00% during the quarter.

Gallacher Capital Management LLC has a history of taking positions in derivatives of the underlying security (FLNA) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MX:FLNA / Filana Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F FILANA THERAPEUTICS COM 14817C107 64,972 -3 -0.00 110 -14.84 0.0421
2026-02-03 2025-12-31 13F CASSAVA SCIENCES COM 14817C107 64,975 0 0.00 129 -32.28 0.0497
2025-11-05 2025-09-30 13F CASSAVA SCIENCES COM 14817C107 64,975 0 0.00 189 61.54 0.0748
2025-07-08 2025-06-30 13F CASSAVA SCIENCES COM 14817C107 64,975 -4,685 -6.73 118 12.50 0.0544
2025-05-05 2025-03-31 13F CASSAVA SCIENCES COM 14817C107 69,660 -83,286 -54.45 104 -71.11 0.0509
2025-02-10 2024-12-31 13F CASSAVA SCIENCES COM 14817C107 152,946 -427,096 -73.63 361 -97.89 0.1791
2024-11-12 2024-09-30 13F CASSAVA SCIENCES COM 14817C107 580,042 -2,446 -0.42 17,071 137.31 7.8346
2024-08-06 2024-06-30 13F CASSAVA SCIENCES COM 14817C107 582,488 -2,893 -0.49 7,194 -39.44 3.7860
2024-05-06 2024-03-31 13F CASSAVA SCIENCES COM 14817C107 585,381 3,775 0.65 11,877 -9.27 6.0286
2024-02-06 2023-12-31 13F CASSAVA SCIENCES COM 14817C107 581,606 3,782 0.65 13,092 36.17 7.2995
2023-11-13 2023-09-30 13F CASSAVA SCIENCES COM 14817C107 577,824 -5,468 -0.94 9,615 -32.78 6.0022
2023-08-11 2023-06-30 13F CASSAVA SCIENCES COM 14817C107 583,292 -4,627 -0.79 14,302 0.86 8.2577
2023-05-12 2023-03-31 13F CASSAVA SCIENCES COM 14817C107 587,919 -614 -0.10 14,181 -18.44 8.5058
2023-01-17 2022-12-31 13F CASSAVA SCIENCES COM 14817C107 588,533 588,533 17,385 10.5195
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-05-05 2025-03-31 13F CASSAVA SCIENCES COM Call 0 -100.00 0 n/a n/a n/a
2025-02-10 2024-12-31 13F CASSAVA SCIENCES COM Call 19,800 -15.38 0 -100.00 n/a n/a n/a
2024-11-12 2024-09-30 13F CASSAVA SCIENCES COM Call 23,400 45.34 336 477.59 n/a n/a n/a
2024-08-06 2024-06-30 13F CASSAVA SCIENCES COM Call 16,100 59 n/a n/a n/a
2023-11-13 2023-09-30 13F CASSAVA SCIENCES COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-08-11 2023-06-30 13F CASSAVA SCIENCES COM Call 17,300 14 n/a n/a n/a
2023-05-12 2023-03-31 13F CASSAVA SCIENCES COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-01-17 2022-12-31 13F CASSAVA SCIENCES COM Call 50,100 26 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.